Valeant Headquarters Moving to Montreal Region
From DermWire
Earnings & Financials
Valeant Pharmaceuticals is relocating its global headquarters to the Montreal region and will establish the Laboratore Dr. Renaud Centre of Excellence—a R&D center for consumer dermatology—in Laval, Quebec. Laboratoire Dr. Renaud and a newly acquired manufacturing facility will function as critical components of the Company's emerging position as a major player in dermatology. The team at Laboratoire Dr. Renaud will be dedicated to combining new active ingredients with proprietary formulation techniques.
- ThromboGenics Provides Business and Financial Upda...5/16/2013
- MorphoSys Announces Clinical Milestone in Ophthalm...5/3/2013
- Allergan Delays Drug That Would Rival Regeneron's ...5/2/2013
- Novaliq GmbH Raises $18.1 million in 5th Round of ...4/11/2013
- GenSight Receives $41.3 Million for Ocular Gene Th...4/8/2013
- Whats In a Name?4/22/2013
- Waiting Game: A Look at the Business Impacts of Pa...4/22/2013
- A State of Transition for EHRs4/22/2013
- PR Is the Next Big Thing for Online Dermatology Ma...4/22/2013